Researchers present first complete control map for KRAS, laying out a fresh blueprint for targeting ‘undruggable’ proteins. Researchers at the Centre for Genomic Regulation in Barcelona, Spain, and the Wellcome Sanger Institute near Cambridge, UK, have compre…